Literature DB >> 9876221

Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.

B B Tysnes1, H K Haugland, R Bjerkvig.   

Abstract

Gliomas are characterized by their extensive invasion into the brain parenchyma. Recently it has been shown that normal brain cells can produce laminin, fibronectin and collagen type IV when confronted by invading glioma cells. Laminin stimulates cell migration of several human glioma cell lines in vitro. This migration can be inhibited by adding blocking monoclonal antibodies (MAbs) against the most expressed integrin subunits, alpha3 and beta1. Previous studies have shown that glioma cell migration, invasion and growth are stimulated by epidermal growth factor (EGF). However, MAb directed against the EGF receptor (EGFR) did only partly inhibit the invasive process in vitro. Since laminin has regional peptide homology with EGF (EGF-like repeats), the present work was aimed at studying how two human glioma cell lines exposed to antibodies to the EGFR, reacted to laminin stimulated migration. Furthermore, we wanted to study which role the EGFR and the laminin receptor integrin subunits alpha3 and beta1 play during glioma cell invasion. EGFR expression of two glioma cell lines, AN1/lacZ and U-251/lacZ was studied by flow cytometry and immunofluorescence microscopy. A cell migration assay was used to study effects of MAbs against EGFR on migration from laminin-stimulated tumor spheroids. Tumor cell invasion was evaluated by using an in vitro co-culture model, where normal fetal brain cell aggregates were confronted with multicellular tumor spheroids. The results show that both cell lines expressed EGFR, AN1/lacZ 4-fold more than U-251/lacZ. MAb against EGFR inhibited the laminin-stimulated migration only from AN1/lacZ spheroids. MAbs against alpha3 and beta1 integrin subunits inhibited glioma cell invasion in vitro. The present work indicates possible connections between laminin-stimulated cell migration and the EGFR expression on glioma cells. These elements contribute to the characteristic features of glioma cells and may be an important part of the complex relationships between growth factors, integrins and extracellular matrix during glioma cell invasion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9876221

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  12 in total

1.  Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10.

Authors:  Toshiyuki Murai; Takayuki Miyauchi; Toshio Yanagida; Yasushi Sako
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

2.  MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.

Authors:  Mark Katakowski; Xuguang Zheng; Feng Jiang; Thomas Rogers; Alexandra Szalad; Michael Chopp
Journal:  Cancer Invest       Date:  2010-09-27       Impact factor: 2.176

Review 3.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 4.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Bromelain reversibly inhibits invasive properties of glioma cells.

Authors:  B B Tysnes; H R Maurer; T Porwol; B Probst; R Bjerkvig; F Hoover
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

6.  Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.

Authors:  Fei Wang; Rhonda K Hansen; Derek Radisky; Toshiyuki Yoneda; Mary Helen Barcellos-Hoff; Ole W Petersen; Eva A Turley; Mina J Bissell
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

7.  Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation.

Authors:  Andrew A Jarjour; Margaret Durko; Tamarah L Luk; Nathalie Marçal; Masoud Shekarabi; Timothy E Kennedy
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

8.  The natural history of EGFR and EGFRvIII in glioblastoma patients.

Authors:  Amy B Heimberger; Dima Suki; David Yang; Weiming Shi; Kenneth Aldape
Journal:  J Transl Med       Date:  2005-10-19       Impact factor: 5.531

9.  MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.

Authors:  Yong Lu; Michael Chopp; Xuguang Zheng; Mark Katakowski; Benjamin Buller; Feng Jiang
Journal:  Oncol Rep       Date:  2012-10-17       Impact factor: 3.906

10.  Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.

Authors:  L Gerard Toussaint; Allan E Nilson; Jennie M Goble; Karla V Ballman; C David James; Florence Lefranc; Robert Kiss; Joon H Uhm
Journal:  Mol Cancer       Date:  2012-05-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.